Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Petrochemical Development Corporation (CPDC) is a leading Taiwanese producer of petrochemicals, engineering plastics, synthetic resins, and raw materials for chemical fiber and related products. Founded in 1969 as a state-owned enterprise and privatized in 1994, CPDC operates major production bases across Taiwan and Asia. While its primary focus is on chemicals and industrial materials, it also owns Taivex Therapeutics Inc., which develops novel anti-cancer drugs targeting Hec1-Nek2 interactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Petrochemical Development Corporation.